Top compounds associated with response to NFATC2


Feature Type Standardized
Nominal ANOVA
mRNA MS-275 gCSI pan-cancer AAC 0.00078 1
mRNA BRD-K30019337 CTRPv2 pan-cancer AAC -0.00082 1
mRNA PRIMA-1-Met CTRPv2 pan-cancer AAC -0.00061 1
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.00022 1
Download CSV